Konex

Mometasone furoate, the active ingredient in Konex, is a corticosteroid presented as a topical formulation for skin use. It is prescribed to manage inflammatory skin conditions such as psoriasis, eczema and dermatitis. GNH USA supplies Konex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Konex, a corticosteroid, is applied to treat inflammatory skin disorders. - Psoriasis: reduces scaling, redness and plaque thickness. - Eczema: alleviates itching, inflammation and skin irritation. - Dermatitis: diminishes redness, swelling and discomfort associated with dermatitis.

Topical corticosteroids may cause local and systemic adverse reactions. Common Side Effects: - Skin burning or stinging at the application site. - Mild itching or dryness. - Redness or irritation. - Folliculitis or acneiform eruptions. - Temporary worsening of eczema. Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Telangiectasia (visible blood vessels). - Secondary bacterial, fungal or viral skin infections. - Systemic adrenal suppression, especially with extensive application. - Hypersensitivity reactions such as urticaria or angioedema.

Konex should be used according to prescriber instructions and monitored for safety. - Application area: limit to affected skin and avoid large surface areas. - Duration: use for the shortest effective period to reduce risk of skin atrophy. - Occlusion: avoid covering treated skin unless directed by a healthcare professional. - Concomitant therapy: do not combine with other potent topical steroids without medical advice. - Pediatric use: exercise caution in children due to higher absorption risk. Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Topical corticosteroids can interact with other agents applied to the skin or systemic drugs. Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic adrenal suppression. - Potent immunosuppressants: can exacerbate local infection risk. - Antifungal or antibacterial creams: may reduce efficacy of either product. Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied topically: may increase irritation. - Skin sensitizers (e.g., retinoids): could heighten local irritation. - Phototherapy: may enhance skin thinning when combined with potent steroids.